Other: blood collection for measurement of eculizumab peak concentrations (DrugBank: Eculizumab)
8 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
11 | 重症筋無力症 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
14 | 慢性炎症性脱髄性多発神経炎/多巣性運動ニューロパチー | 0 |
61 | 自己免疫性溶血性貧血 | 0 |
62 | 発作性夜間ヘモグロビン尿症 | 1 |
109 | 非典型溶血性尿毒症症候群 | 0 |
222 | 一次性ネフローゼ症候群 | 0 |
223 | 一次性膜性増殖性糸球体腎炎 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04079257 (ClinicalTrials.gov) | October 2020 | 11/7/2019 | The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria | The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria | Paroxysmal Nocturnal Hemoglobinuria;Eculizumab;PK-PD | Other: Blood collection for measurement of eculizumab peak concentrations | Radboud University | NULL | Not yet recruiting | 18 Years | N/A | All | 60 | NULL |